Quality assessment of robot assisted thoracic surgical resection of non-small cell lung cancer: nodal upstaging and mediastinal recurrence
- PMID: 33717532
- PMCID: PMC7947478
- DOI: 10.21037/jtd-20-2267
Quality assessment of robot assisted thoracic surgical resection of non-small cell lung cancer: nodal upstaging and mediastinal recurrence
Abstract
Background: Robot assisted thoracic surgery (RATS) is the minimally invasive surgical technique of choice for treatment of patients with non-small cell lung cancer (NSCLC), at the Isala Hospital. The aim of this study is to compare clinical and pathological staging results and mediastinal recurrence after RATS for anatomical resections of lung cancer as surrogate markers for quality of mediastinal lymph node dissection (MLND).
Methods: This single institute retrospective study was conducted in patients who underwent RATS for NSCLC. Excluded were patients with a history of concurrent malignant disease, with other previous neoplasms, with small cell lung cancer (SCLC) and patients in whom the robotic technique was converted to thoracotomy, prior to lymph node dissection. Data were obtained from the hospital database. The difference between clinical and pathological staging was expressed as upstaging and downstaging. Computed Tomography scanning was used for follow-up, and diagnosis of mediastinal recurrence.
Results: From November 2011 to May 2016, 227 patients underwent RATS at Isala Hospital Zwolle, the Netherlands. Of those, 130 (mean age, 69.5±9.3 years) met the eligibility criteria. Preoperative mediastinal lymph node staging was done by endoscopic ultrasound/endobronchial ultrasound, by positron emission tomography (PET) or mediastinoscopy. In 14 patients (10.8%) unforeseen N2 disease was found, 6 patients (4.6%) were upstaged from cN0 to pN2 and 8 patients (6.2%) were upstaged from cN1 to pN2. Mediastinal recurrence was detected in 7 patients (5.4%) during a median follow-up of 54 months (range, 1.5-102 months).
Conclusions: In patients with NSCLC, who underwent anatomical resection by means of RATS, an unforeseen N2 disease rate of 10.8% was demonstrated and a mediastinal recurrence rate of 5.4%. It is concluded that robotic surgery provides an accurate lymph node dissection.
Keywords: Non-small cell lung cancer (NSCLC); lymph node dissection; mediastinal recurrence; robot assisted thoracic surgery (RATS).
2021 Journal of Thoracic Disease. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-2267). GMS reports that she is proctor for Intuitive Surgical Inc. The other authors have no conflicts of interest to declare.
Similar articles
-
A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.Surg Endosc. 2016 Mar;30(3):1119-25. doi: 10.1007/s00464-015-4312-9. Epub 2015 Jul 14. Surg Endosc. 2016. PMID: 26169635
-
MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial.BMC Surg. 2018 May 18;18(1):27. doi: 10.1186/s12893-018-0359-6. BMC Surg. 2018. PMID: 29776444 Free PMC article. Clinical Trial.
-
The dutch national clinical audit for lung cancer: A tool to improve clinical practice? An analysis of unforeseen ipsilateral mediastinal lymph node involvement in the Dutch Lung Surgery Audit (DLSA).Eur J Surg Oncol. 2018 Jun;44(6):830-834. doi: 10.1016/j.ejso.2017.12.002. Epub 2018 Jan 9. Eur J Surg Oncol. 2018. PMID: 29396329
-
Invasive mediastinal staging by endosonography or video-assisted mediastinoscopy in PET-CT clinical N1 non-small cell lung cancer.Mediastinum. 2020 Mar 25;4:6. doi: 10.21037/med.2019.12.01. eCollection 2020. Mediastinum. 2020. PMID: 35118274 Free PMC article. Review.
-
Nodal upstaging: effects of instrumentation and three-dimensional view in clinical stage I lung cancer.J Vis Surg. 2017 May 30;3:76. doi: 10.21037/jovs.2017.04.05. eCollection 2017. J Vis Surg. 2017. PMID: 29078639 Free PMC article. Review.
Cited by
-
Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer.Front Oncol. 2023 Feb 23;13:1134713. doi: 10.3389/fonc.2023.1134713. eCollection 2023. Front Oncol. 2023. PMID: 36910671 Free PMC article.
-
Lung Cancer Surgery after Neoadjuvant Immunotherapy.Cancers (Basel). 2021 Aug 10;13(16):4033. doi: 10.3390/cancers13164033. Cancers (Basel). 2021. PMID: 34439187 Free PMC article. Review.
-
Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer.J Clin Med. 2022 Apr 13;11(8):2173. doi: 10.3390/jcm11082173. J Clin Med. 2022. PMID: 35456265 Free PMC article.
-
Robot-assisted thoracic surgery for stages IIB-IVA non-small cell lung cancer: retrospective study of feasibility and outcome.J Robot Surg. 2023 Aug;17(4):1587-1598. doi: 10.1007/s11701-023-01549-3. Epub 2023 Mar 16. J Robot Surg. 2023. PMID: 36928749 Free PMC article.
-
Robotic-assisted mediastinal lymphadenectomy in lung cancer: a narrative review.J Robot Surg. 2025 Jun 4;19(1):263. doi: 10.1007/s11701-025-02392-4. J Robot Surg. 2025. PMID: 40464809 Review.
References
-
- Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:234S-242S. - PubMed
-
- Howlader N, Noone AM, Krapcho M, et al. editors. National Cancer Institute Bethesda, MD. Available online: https://seer.cancer.gov/csr/1975_2017 SEER Cancer Statistics Review 1975-2017.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous